Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-02-22 @ 5:22 PM
Study NCT ID:
NCT04671251
Status:
COMPLETED
Last Update Posted:
2024-02-29
First Post:
2020-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor:
Avalo Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords: